There is limited uptake of Covid-19 treatments targeted at immunocompromised people and those who aren’t responsive to Covid-19 vaccines, largely for reasons that remain unclear. Meanwhile, demand for antivirals appears to be slowing, even as manufacturing capacity ramps up. The whole article was published by Chemistry World.
IMAGE: Jernej Furman — Flickr